AGM Trading Update

Genus (LSE: GNS), a leading global animal genetics company, publishes the following unaudited trading update for the four months ending 31 October 2025 to coincide with its AGM at 11:00am GMT this morning.

Genus has had a strong start to the year and the Board expects Group FY26 adjusted profit before tax to be modestly ahead of the midpoint of current market expectations1.

PIC trading continued to be strong with every region achieving royalty revenue and adjusted operating profit growth2. PIC performed particularly well in China with strong royalty revenue growth being a key driver.

ABS adjusted operating profit2 has been slightly lower than expected due to phasing. Management expects a step up in performance in the second half. Value Acceleration Programme Phase 3 initiatives are progressing as planned.

Genus will announce its interim results for the six month period from 1 July 2025 to 31 December 2025 on 26 February 2026.

Jorgen Kokke, CEO of Genus, said:

"Genus has made a strong start to the year with PIC continuing to demonstrate its robust growth model. ABS profit performance has been slightly lower than expected but we expect stronger performance in the second half. We look forward to the rest of the year with confidence."

Footnotes

1 The Company compiled consensus estimate range for Group FY26 actual currency adjusted profit before tax is £77.6m to £85.0m with an average midpoint of £80.5m, and is based upon 8 analyst estimates. These forecasts exclude any impact from the Chinese porcine joint venture formation announced on 4 September 2025.

2 In constant currency